Home Novel mutations of DAX1 (NR0B1) in two Chinese families with X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism
Article
Licensed
Unlicensed Requires Authentication

Novel mutations of DAX1 (NR0B1) in two Chinese families with X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism

  • Guijun Qin EMAIL logo , Hongfei Ji , Xialian Li , Xiaokun Ma and Danping Wang
Published/Copyright: May 13, 2015

Abstract

Objective: To analyze the DAX1 (NR0B1) (dosage-sensitive sex reversal-adrenal hypoplasia congenita (AHC) critical region on the X chromosome gene 1) gene in two Chinese families with AHC and hypogonadotrophic hypogonadism (HHG).

Patients and methods: Two families with 4 affected males, 5 carrier females, and 4 unaffected males were investigated. Sequencing of the entire 1413-bp coding region of DAX1 (NR0B1) gene was performed in both patients and their family members.

Results: Two different novel DAX1 (NR0B1) mutations located within exon 1, an insertional mutation at codon 35 leading to a frameshift and a premature stop at codon 46, and a deletion mutation at codon 331 leading to a frameshift and a premature stop at codon 371 were detected. The mothers and sisters of the patients were heterozygotes for the mutations, while their fathers did not carry the mutations.

Conclusions: Two novel DAX1 (NR0B1) mutations were detected in two Chinese families. These data indicate that molecular analysis of the DAX1 (NR0B1) gene is important for the diagnosis and genetic counseling of children with primary adrenal insufficiency.


Corresponding author: Guijun Qin, Division of Endocrinology, Department of Internal Medicine, The First Affiliated Hospital of Zhengzhou University, 40 Daxue Road, Zhengzhou 450052, People’s Republic of China, E-mail:

References

1. Sikl H. Addison’s disease due to congenital hypoplasia of the adrenals in an infant aged 33 days. J Pathol Bactertiol 1948;60:323–6.10.1002/path.1700600220Search in Google Scholar

2. Zanaria E, Muscatelli F, Bardoni B, Strom TM, Guioli S, et al. An unusual member of the nuclear hormone receptor superfamily responsible for X-linked adrenal hypoplasia congenita. Nature 1994;372:635–41.10.1038/372635a0Search in Google Scholar

3. Lin L, Gu WX, Ozisik G, To WS, Owen CJ, et al. Analysis of DAX1 (NR0B1) and steroidogenic factor-1 (NR5A1) in children and adults with primary adrenal failure: ten years’ experience. J Clin Endocrinol Metab 2006;91:3048–54.10.1210/jc.2006-0603Search in Google Scholar

4. Kletter GB, Gorski JL, Kelch RP. Congenital adrenalhypoplasia and isolated gonadotropin deficiency. Trends Endocrinol Metab 1991;2:123–8.10.1016/1043-2760(91)90001-4Search in Google Scholar

5. Achermann JC, Vilain EJ. X-Linked Adrenal hypoplasia congenita. In: Pagon RA, Adam MP, Bird TD, Dolan CR, Fong CT, Stephens K, editors. GeneReviews [Internet]. Seattle (WA): University of Washington, Seattle, 1993–2013.Search in Google Scholar

6. Ponikwicka-Tyszko D, Kotula-Balak M, Jarzabek K, Bilinska B, Wolczynski S. The DAX1 mutation in a patient with hypogonadotropic hypogonadism and adrenal hypoplasia congenita causes functional disruption of induction of spermatogenesis. J Assist Reprod Genet 2012;29:811–6.10.1007/s10815-012-9778-ySearch in Google Scholar PubMed PubMed Central

7. Barbaro M, Bens S, Haake A, Peter M, Brämswig J, et al. Multiplex ligation-dependent probe amplification analysis of the NR0B1(DAX1) locus enables explanation of phenotypic differences in patients with X-linked congenital adrenal hypoplasia. Horm Res Paediatr 2012;77:100–7.10.1159/000336344Search in Google Scholar PubMed

8. Evliyaoğlu O, Dokurel İ, Bucak F, Özcabı B, Ercan Ö, et al. Primary adrenal insufficiency caused by a novel mutation in DAX1 gene. J Clin Res Pediatr Endocrinol 2013;5:55–7.10.4274/Jcrpe.895Search in Google Scholar PubMed PubMed Central

9. Skinningsrud B, Husebye ES, Gilfillan GD, Frengen E, Erichsen A, et al. X-linked congenital adrenal hypoplasia with hypogonadotropic hypogonadism caused by an inversion disrupting a conserved noncoding element upstream of the NR0B1 (DAX1) gene. J Clin Endocrinol Metab 2009;94:4086–93.10.1210/jc.2009-0923Search in Google Scholar PubMed

10. Clipsham R, McCabe ER. DAX1 and its network partners: exploring complexity in development. Mol Genet Metab 2003;80:81–120.10.1016/j.ymgme.2003.08.023Search in Google Scholar PubMed

11. Rojek A, Obara-Moszynska M, Malecka E, Slomko-Jozwiak M, Niedziela M. NR0B1 (DAX1) mutations in patients affected by congenital adrenal hypoplasia with growth hormone deficiency as a new finding. J Appl Genet 2013;54:225–30.10.1007/s13353-013-0135-3Search in Google Scholar PubMed

12. Calliari LE, Rocha MN, Monte O, Longui CA. Mild adrenal insufficiency due to a NR0B1 (DAX1) gene mutation in a boy presenting an association of hypogonadotropic hypogonadism, reduced final height and attention deficit disorder. Arq Bras Endocrinol Metabol 2013;57:562–5.10.1590/S0004-27302013000700011Search in Google Scholar PubMed

13. Xu XQ, Feng YY, Yuan WX, Huang K, Liang L, et al. Novel mutations in DAX1 of X-linked adrenal hypoplasia congenita over several generations in one family. Endocr Pract 2013;19: e105–11.10.4158/EP12368.CRSearch in Google Scholar PubMed

14. Esden-Tempska Z, Lewczuk A, Tobias ES, Borozdin W, Kohlhase J, et al. Delayed diagnosis of adrenal hypoplasia congenita in a patient with a new mutation in the NR0B1 gene. J Pediatr Endocrinol Metab 2012;25:147–8.10.1515/jpem.2011.400Search in Google Scholar PubMed

15. Lumaka A, Mubungu G, Nsibu C, Tady BP, Lukusa T, et al. X-linked adrenal hypoplasia congenita: a novel DAX1 missense mutation and challenges for clinical diagnosis in Africa. Eur J Pediatr 2012;171:267–70.10.1007/s00431-011-1523-5Search in Google Scholar PubMed

16. Scheys JO, Heaton JH, Hammer GD. Evidence of adrenal failure in aging Dax1-deficient mice. Endocrinology 2011;152: 3430–39.10.1210/en.2010-0986Search in Google Scholar PubMed PubMed Central

17. Jadhav U, Harris RM, Jameson JL. Hypogonadotropic hypogonadism in subjects with DAX1 mutations. Mol Cell Endocrinol 2011;346:65–73.10.1016/j.mce.2011.04.017Search in Google Scholar PubMed PubMed Central

18. Frapsauce C, Ravel C, Legendre M, Sibony M, Mandelbaum J, et al. Birth after TESE-ICSI in a man with hypogonadotropic hypogonadism and congenital adrenal hypoplasia linked to a DAX-1 (NR0B1) mutation. Hum Reprod 2011;26:724–8.10.1093/humrep/deq372Search in Google Scholar PubMed PubMed Central

19. Ozer EA, Kaya A, Yildirimer M, Guler O, Can S, et al. A novel DAX1 gene mutation in a Turkish infant with X-linked adrenal hypoplasia congenita. Eur J Pediatr 2011;168:367–9.10.1007/s00431-008-0778-ySearch in Google Scholar PubMed

20. Mericq V, Ciaccio M, Marino R, Lamoglia JJ, Viterbo G, et al. A new DAX-1 mutation in a family with a case of neonatal adrenal insufficiency and a sibling with adrenal hypoplasia and sudden death at 3 years of age. J Pediatr Endocrinol Metab 2007;20:1039–43.10.1515/JPEM.2007.20.9.1039Search in Google Scholar PubMed

21. Bassett JH, O’Halloran DJ, Williams GR, Beardwell CG, Shalet SM, et al. Novel DAX1 mutations in X-linked adrenal hypoplasia congenita and hypogonadotrophic hypogonadism. Clin Endocrinol (Oxf) 1999;50:69–75.10.1046/j.1365-2265.1999.00601.xSearch in Google Scholar PubMed

22. Ozisik G, Mantovani G, Achermann JC, Persani L, Spada A, et al. An alternate translation initiation site circumvents an amino-terminal DAX1 nonsense mutation leading to a mild form of X-linked adrenal hypoplasia congenita. J Clin Endocrinol Metab 2003;88:417–23.10.1210/jc.2002-021034Search in Google Scholar PubMed

23. Habiby RL, Boepple P, Nachtigall L, Sluss PM, Crowley WF Jr, et al. Adrenal hypoplasia congenita with hypogonadotropic hypogonadism: evidence that DAX-1 mutations lead to combined hypothalamic and pituitary defects in gonadotropin production. J Clin Invest 1996;98:1055–62.10.1172/JCI118866Search in Google Scholar PubMed PubMed Central

Received: 2014-4-14
Accepted: 2014-12-8
Published Online: 2015-5-13
Published in Print: 2015-7-1

©2015 by De Gruyter

Articles in the same Issue

  1. Frontmatter
  2. Highlight: Thyroid
  3. Thyroid disorders revisited
  4. Genetic analysis of the paired box transcription factor (PAX8) gene in a cohort of Polish patients with primary congenital hypothyroidism and dysgenetic thyroid glands
  5. Prognostic factors in pediatric differentiated thyroid cancer patients with pulmonary metastases
  6. Reclassification of cytologically atypical thyroid nodules based on radiologic features in pediatric patients
  7. Evaluation of inflammatory and oxidative biomarkers in children with well-controlled congenital hypothyroidism
  8. Investigation of autoimmune diseases accompanying Hashimoto’s thyroiditis in children and adolescents and evaluation of cardiac signs
  9. Neonatal thyroid storm accompanied with severe anaemia
  10. Functional characterization of the novel sequence variant p.S304R in the hinge region of TSHR in a congenital hypothyroidism patients and analogy with other formerly known mutations of this gene portion
  11. Subclinical hypothyroidism as a rare cofactor in chronic kidney disease (CKD) – related anemia
  12. Cytometric analysis of perforin expression in NK cells, CD8+, and CD4+ lymphocytes in children with autoimmune Hashimoto’s thyroiditis – a preliminary study
  13. Papillary thyroid cancer and autoimmune polyglandular syndrome
  14. Review article
  15. Should radioiodine be the first-line treatment for paediatric Graves’ disease?
  16. Image in pediatric endrocrinology
  17. Diffusion-weighted magnetic resonance imaging in a case of severe classic maple syrup urine disease
  18. Original articles
  19. Novel mutations of DAX1 (NR0B1) in two Chinese families with X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism
  20. Rickets and vitamin D deficiency in Alaska native children
  21. Persistent elevation of fibroblast growth factor 23 concentrations in healthy appropriate-for-gestational-age preterm infants
  22. Parents’ experiences of having a baby with ambiguous genitalia
  23. Effect of GnRHa 3.75 mg subcutaneously every 6 weeks on adult height in girls with idiopathic central precocious puberty
  24. Congenital adrenal hyperplasia in children – a survey on the current practice in the UK
  25. Randomized clinical trial evaluating metformin versus oral contraceptive pills in the treatment of adolescents with polycystic ovarian syndrome
  26. Influence of the body weight on the onset and progression of puberty in boys
  27. Therapy monitoring in congenital adrenal hyperplasia by dried blood samples
  28. Hyperinsulinemic hypoglycemia: think of hyperinsulinism/hyperammonemia (HI/HA) syndrome caused by mutations in the GLUD1 gene
  29. Sulfonylurea in the treatment of neonatal diabetes mellitus children with heterogeneous genetic backgrounds
  30. Monitoring gonadotropin-releasing hormone analogue (GnRHa) treatment in girls with central precocious puberty: a comparison of four methods
  31. Dietary intake, body composition, and physical activity among young patients with type 1 diabetes mellitus
  32. Metabolic syndrome in obese children and adolescents in Serbia: prevalence and risk factors
  33. Progressive osseous heteroplasia, as an isolated entity or overlapping with Albright hereditary osteodystrophy
  34. Patient reports
  35. 17α-Hydroylase/17,20-lyase deficiency related to P.Y27*(c.81C>A) mutation in CYP17A1 gene
  36. A patient developing anaphylaxis and sensitivity to two different GnRH analogues and a review of literature
  37. Idiopathic short stature due to novel heterozygous mutation of the aggrecan gene
  38. Triple A syndrome with a novel indel mutation in the AAAS gene and delayed puberty
  39. Case report: long-term follow-up of a 45,X male with SHOX haploinsufficiency
  40. Antenatal Bartter syndrome presenting as hyperparathyroidism with hypercalcemia and hypercalciuria: a case report and review
  41. Successful use of continuous subcutaneous hydrocortisone infusion after bilateral adrenalectomy secondary to bilateral pheochromocytoma
  42. Donohue syndrome: a new case with a new complication
  43. Euprolactinemic galactorrhea secondary to domperidone treatment
  44. 17βHSD-3 enzyme deficiency due to novel mutations in the HSD17B3 gene diagnosed in a neonate
  45. Two different patterns of mini-puberty in two 46,XY newborns with 17β-hydroxysteroid dehydrogenase type 3 deficiency
  46. Short communication
  47. Early onset hearing loss in autosomal recessive hypophosphatemic rickets caused by loss of function mutation in ENPP1
Downloaded on 12.10.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2014-0156/html
Scroll to top button